ATE418974T1 - Fettsäure-analogen zur behandlung proliferierender hautstörungen - Google Patents

Fettsäure-analogen zur behandlung proliferierender hautstörungen

Info

Publication number
ATE418974T1
ATE418974T1 AT01975050T AT01975050T ATE418974T1 AT E418974 T1 ATE418974 T1 AT E418974T1 AT 01975050 T AT01975050 T AT 01975050T AT 01975050 T AT01975050 T AT 01975050T AT E418974 T1 ATE418974 T1 AT E418974T1
Authority
AT
Austria
Prior art keywords
sub
carbon
omega
alkyl
fatty acid
Prior art date
Application number
AT01975050T
Other languages
English (en)
Inventor
Rolf Berge
Karsten Kristiansen
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Application granted granted Critical
Publication of ATE418974T1 publication Critical patent/ATE418974T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
AT01975050T 2000-09-27 2001-09-27 Fettsäure-analogen zur behandlung proliferierender hautstörungen ATE418974T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20004844A NO20004844L (no) 2000-09-27 2000-09-27 Fettsyre analoger for behandling av proliferative hudsykdommer

Publications (1)

Publication Number Publication Date
ATE418974T1 true ATE418974T1 (de) 2009-01-15

Family

ID=19911618

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01975050T ATE418974T1 (de) 2000-09-27 2001-09-27 Fettsäure-analogen zur behandlung proliferierender hautstörungen

Country Status (17)

Country Link
US (1) US7230029B2 (de)
EP (1) EP1324756B1 (de)
JP (1) JP2004509917A (de)
KR (1) KR100905336B1 (de)
CN (1) CN100579521C (de)
AT (1) ATE418974T1 (de)
AU (2) AU9441901A (de)
BR (1) BR0114137A (de)
CA (1) CA2421729A1 (de)
DE (1) DE60137243D1 (de)
ES (1) ES2317938T3 (de)
HK (1) HK1060692A1 (de)
MX (1) MXPA03002629A (de)
NO (1) NO20004844L (de)
NZ (1) NZ524599A (de)
RU (1) RU2276602C2 (de)
WO (1) WO2002026218A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
CA2490121C (en) 2002-06-20 2013-01-08 Ic Vec Limited Modified phospholipids
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
KR20070046866A (ko) * 2004-07-19 2007-05-03 티아 메디카 에이에스 단백질 물질 및 비-산화성 지방산 구성요소를 포함하는조성물
US20100104546A1 (en) * 2007-02-05 2010-04-29 Children, Youth And Women's Health Service Modulators of antigen-dependent t cell proliferation
US8602833B2 (en) 2009-08-06 2013-12-10 May Patents Ltd. Puzzle with conductive path
US9019718B2 (en) 2011-08-26 2015-04-28 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US11330714B2 (en) 2011-08-26 2022-05-10 Sphero, Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
US9597607B2 (en) 2011-08-26 2017-03-21 Littlebits Electronics Inc. Modular electronic building systems with magnetic interconnections and methods of using the same
USD732475S1 (en) 2012-11-19 2015-06-23 Littlebits Electronics Inc. Connector for modular electronic building system
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN109996532A (zh) 2016-10-04 2019-07-09 玫琳凯有限公司 用于处理萎缩纹的方法和组合物
AU2019340475A1 (en) * 2018-09-14 2021-03-11 Université de Lausanne Methods for modulating regulatory T cells and inhibiting tumor growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
DE19516705C2 (de) * 1995-05-06 1997-10-02 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Substanzen
FR2792312B1 (fr) * 1999-04-15 2001-06-08 Oreal Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
AUPQ291499A0 (en) 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger

Also Published As

Publication number Publication date
NO20004844L (no) 2002-05-10
CN1466453A (zh) 2004-01-07
BR0114137A (pt) 2003-08-12
DE60137243D1 (de) 2009-02-12
EP1324756A2 (de) 2003-07-09
WO2002026218A2 (en) 2002-04-04
US20040019108A1 (en) 2004-01-29
KR100905336B1 (ko) 2009-07-01
KR20030036843A (ko) 2003-05-09
NZ524599A (en) 2004-11-26
AU2001294419B2 (en) 2005-12-01
RU2276602C2 (ru) 2006-05-20
NO20004844D0 (no) 2000-09-27
EP1324756B1 (de) 2008-12-31
MXPA03002629A (es) 2004-05-24
JP2004509917A (ja) 2004-04-02
CN100579521C (zh) 2010-01-13
AU9441901A (en) 2002-04-08
US7230029B2 (en) 2007-06-12
HK1060692A1 (en) 2004-08-20
ES2317938T3 (es) 2009-05-01
CA2421729A1 (en) 2002-04-04
WO2002026218A3 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
PT1075259E (pt) Novos analogos gordos para o tratamento de diabetes
ATE418974T1 (de) Fettsäure-analogen zur behandlung proliferierender hautstörungen
DE60118198D1 (de) Fettsäure-analoge zur behandlung von krebs
BR0108950A (pt) Novos análogos de ácido graxo
NO20014240L (no) C16-umettede FP-selektive prostaglandinanaloger
ATE416174T1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties